| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/09/2011 | WO2011069046A1 Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema |
| 06/09/2011 | WO2011069038A2 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| 06/09/2011 | WO2011069037A2 Stabilization and storage of biological pharmaceutical compositions |
| 06/09/2011 | WO2011068993A1 Compositions and methods for increasing serum half-life of fc fusion proteins. |
| 06/09/2011 | WO2011068893A1 BINDING PROTEINS THAT BIND TO HUMAN FGFR1C, HUMAN β-KLOTHO AND BOTH HUMAN FGFR1C AND HUMANβ-KLOTHO |
| 06/09/2011 | WO2011068853A2 TREATMENT OF IgE-MEDIATED DISEASE |
| 06/09/2011 | WO2011068703A2 Methods of modulating inflammation in preterm infants using carotenoids |
| 06/09/2011 | WO2011068019A1 Retrograde transport viral vector system having envelope comprising fused glycoprotein |
| 06/09/2011 | WO2011067983A1 Adipocyte sheet, three-dimensional structure thereof, and method for producing the same |
| 06/09/2011 | WO2011067624A1 Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer |
| 06/09/2011 | WO2011067420A1 Arf6 as a new target for treating alzheimer's disease |
| 06/09/2011 | WO2011067335A1 Use of defensins for treatment of infective endocarditis |
| 06/09/2011 | WO2011067317A1 Pharmaceutical compositions for the stimulation of stem cells. |
| 06/09/2011 | WO2011067160A1 Von willebrand factor specific binding agents and uses thereof |
| 06/09/2011 | WO2011066869A1 Beta-hairpin peptidomimetics |
| 06/09/2011 | WO2011066711A1 Specific antigen of clonorchis sinensis and uses thereof |
| 06/09/2011 | WO2011066659A1 Method of regulating ppar, obesity related pathways and their associated metabolic impact |
| 06/09/2011 | WO2011066656A1 Compositions comprising igf1 agonists and uses thereof |
| 06/09/2011 | WO2011009119A9 Compositions and methods for diagnosing and treating fibrotic disorders |
| 06/09/2011 | WO2010052559A8 Cycloundecadepsipeptide compounds and use of said compounds as a medicament |
| 06/09/2011 | US20110138491 Compositions and Method for Epigenetic Modification of Nucleic Acid Sequences in Vivo |
| 06/09/2011 | US20110137013 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 06/09/2011 | US20110136747 Use of tight junction antagonists to treat inflammatory bowl disease |
| 06/09/2011 | US20110136746 Kallikrein-Binding "Kunitz Domain" Proteins and Analogues Thereof |
| 06/09/2011 | US20110136745 Method of selecting soybeans with enhanced bioactivity and compositions for reducing cancer cell viability |
| 06/09/2011 | US20110136744 Cyclosporin analog formulations |
| 06/09/2011 | US20110136743 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/09/2011 | US20110136742 Antidepressant prodrugs |
| 06/09/2011 | US20110136741 Dicarba-analogues of octreotide |
| 06/09/2011 | US20110136740 CYSTINE KNOT PEPTIDES BINDING TO ALPHA IIb BETA 3 INTEGRINS AND METHODS OF USE |
| 06/09/2011 | US20110136739 Use of S1P Receptor Agonists in Heart Diseases |
| 06/09/2011 | US20110136738 Alternatively Transcribed Genes Associated with Schizophrenia |
| 06/09/2011 | US20110136737 DPP-IV Resistant GIP Hybrid Polypeptides with Selectable Properties |
| 06/09/2011 | US20110136736 New insulin analogues of prolonged activity |
| 06/09/2011 | US20110136735 Cyclohexane derivatives and uses thereof |
| 06/09/2011 | US20110136734 Methods of Modulating Inflammation in Preterm Infants Using Carotenoids |
| 06/09/2011 | US20110136733 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110136732 Infant nutritional compositions for preventing obesity |
| 06/09/2011 | US20110136730 "Method for screening compounds comprising the use of picornavirus protease 2A" |
| 06/09/2011 | US20110136729 Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans |
| 06/09/2011 | US20110136728 Methods of increasing bone formation using leptin-related peptides |
| 06/09/2011 | US20110136727 Compositions and methods for rapid selection of pathogen binding agents |
| 06/09/2011 | US20110136726 Novel antimicrobial agents |
| 06/09/2011 | US20110136725 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 06/09/2011 | US20110136724 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110136723 Novel reagents and method for conjugating biological molecules |
| 06/09/2011 | US20110136722 Drug Delivery Carrier |
| 06/09/2011 | US20110136221 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 06/09/2011 | US20110135788 Polysiloxane (silicone) treatment composition for suppression of mold and spoilage on animal feed and forage, and methods of using same |
| 06/09/2011 | US20110135742 Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles |
| 06/09/2011 | US20110135741 Sustained-release composition and method for producing the same |
| 06/09/2011 | US20110135736 Compositions and Methods for Producing Vascular Occlusion using a Solid-phase Platelet Binding Agent |
| 06/09/2011 | US20110135733 Aldehyde conjugated flavonoid preparations |
| 06/09/2011 | US20110135732 Multiple phase cross-linked compositions and uses thereof |
| 06/09/2011 | US20110135728 Gastric retentive pharmaceutical compositions for extended release of polypeptides |
| 06/09/2011 | US20110135727 Hepatocyte Delivery Vehicle for Delivery of a Combination of Recombinant Human Regular Insulin and Recombinant Human Insulin Isophane to a Mammal |
| 06/09/2011 | US20110135725 Lipid Construct for Delivery of Insulin to a Mammal |
| 06/09/2011 | US20110135715 Defensin-antigen fusion proteins |
| 06/09/2011 | US20110135712 Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration |
| 06/09/2011 | US20110135708 Dietary supplement - liquid filled gum |
| 06/09/2011 | US20110135707 Polyhydroxyalkanoates for in vivo applications |
| 06/09/2011 | US20110135706 Nerve treatment devices and methods |
| 06/09/2011 | US20110135703 Antimicrobial Coating for Surgical Implants and Method of Use |
| 06/09/2011 | US20110135692 Anti-tumor immunotherapy |
| 06/09/2011 | US20110135687 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/09/2011 | US20110135681 Composition and Method for Enhancing Insulin Activity |
| 06/09/2011 | US20110135676 Novel antiviral peptide against avian influenza virus h9n2 |
| 06/09/2011 | US20110135675 Melanoma associated peptide analogues and vaccines against melanoma |
| 06/09/2011 | US20110135665 Methods for treating reperfusion injuries |
| 06/09/2011 | US20110135661 Treatment and prevention of dry age-related macular degeneration by activating cd36 |
| 06/09/2011 | US20110135660 Prevention and treatment of synucleinopathic disease |
| 06/09/2011 | US20110135655 Role of PI3K p110 delta Signaling in Retroviral Infection and Replication |
| 06/09/2011 | US20110135652 Novel Use of Idbf |
| 06/09/2011 | US20110135651 Method and composition for enhancing hematopoietic stem cell mobilization |
| 06/09/2011 | US20110135649 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof |
| 06/09/2011 | US20110135646 Genes of an Otitis Media Isolate of Nontypeable Haemophilus influenzae |
| 06/09/2011 | US20110135642 Pharmaceutical Compositions Comprising Antibodies Binding To EBV (Ebstein-Barr Virus) Protein BARF1 |
| 06/09/2011 | US20110135641 Radioprotectants targeting thrombospondin-1 and cd47 |
| 06/09/2011 | US20110135639 B lymphocyte stimulator assays |
| 06/09/2011 | US20110135638 Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy |
| 06/09/2011 | US20110135632 Methods for the modulation of angiogenesis |
| 06/09/2011 | US20110135627 Pain relief composition, system and method |
| 06/09/2011 | US20110135626 Localized Chemical Lysis of Ocular Tissue |
| 06/09/2011 | US20110135625 Controlled release enzymatic composition and methods of use |
| 06/09/2011 | US20110135624 Therapeutic composition for autoimmune conditions |
| 06/09/2011 | US20110135623 Conjugates of a Cholinesterase Moiety and a Polymer |
| 06/09/2011 | US20110135622 Presbyopia Treatment by Lens Alteration |
| 06/09/2011 | US20110135621 Inhibiting bacterial infection and biofilm formation |
| 06/09/2011 | US20110135620 Prodrug activation in cancer cells using molecular switches |
| 06/09/2011 | US20110135619 Polypeptides of Alicyclobacillus sp. |
| 06/09/2011 | US20110135618 Methods of treating cancer with doxazolidine and prodrugs thereof |
| 06/09/2011 | US20110135614 Modified growth hormone |
| 06/09/2011 | US20110135607 Viral nucleic acid for the treatment of neurodegenerative disorders |
| 06/09/2011 | US20110135605 Methods and products related to treatment and prevention of hepatitis c virus infection |
| 06/09/2011 | US20110135604 Antiviral compounds |
| 06/09/2011 | US20110135603 Inhibitors of phosphatidylinositol 3-kinase |
| 06/09/2011 | US20110135602 Supperssor of the endogenous interferon-gamma |
| 06/09/2011 | US20110135601 Bicycloaniline derivative |
| 06/09/2011 | US20110135600 Bicyclic traizole derivatives for treating of tumors |
| 06/09/2011 | US20110135599 Antiviral compounds |